4.4 Article

Adaptive Polymersome and Micelle Morphologies in Anticancer Nanomedicine: From Design Rationale to Fabrication and Proof-of-Concept Studies

Journal

ADVANCED THERAPEUTICS
Volume 1, Issue 8, Pages -

Publisher

WILEY
DOI: 10.1002/adtp.201800068

Keywords

adaptive morphologies; drug delivery; nanomedicine; nanotechnology

Funding

  1. National Natural Science Foundation of China [NSFC 51561135010, 51773146, 51633005]
  2. Dutch Ministry of Education, Culture and Science [024.001.035]
  3. NWO-NSFC Advanced Materials [792.001.015]
  4. ERC [694120]
  5. European Union [663830, 676137]
  6. Ser Cymru II programme

Ask authors/readers for more resources

Intrigued and inspired by the intricacy of natural architectures which display various morphologies, researchers seek to develop artificial counterparts in order to replicate, and thereby harness, their function for diverse applications. In particular, well-defined nanoparticles with various morphologies are of great interest for biomedical research. The impact of morphologically discrete nanoparticles upon the development of nanomedicine is significant, gaining increasing attention for its potential to provide a new avenue for the development of future therapeutic technologies. This progress report discusses adaptive morphologies based on block copolymers as platforms for therapeutic and smart drug delivery applications, including design rationale and controlling the morphology of polymeric nanoparticles. The proof-of-concept studies on influence of shapes of nanoparticles on their anticancer effects in vitro and in vivo are addressed.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available